Drug profile · INN
zanamivir
DECTOVA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
zanamivir (DECTOVA) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
INN zanamivir
Brand DECTOVA
Route INHALATION
Formulation POWDER
ATC code J05AH01
Frequently asked questions
What is zanamivir?
zanamivir (DECTOVA) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for zanamivir?
DECTOVA is a marketed brand name for zanamivir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of zanamivir?
zanamivir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.